Lead Product(s): BST204
Therapeutic Area: Nutrition and Weight Loss Product Name: GCWB204
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 25, 2021
The joint research team focused on analyzing the effects of GCWB204 on main biomarkers from animal samples that underwent muscle reduction upon the use of the chemotherapeutic drug 5-Fluorouracil.